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BY-NC-ND license (http://creativecomAbstract Objective: To evaluate the lipid-regulating effect of crude-herb moxibustion on
rats with dyslipidemia.
Methods: Fifty-four SpragueeDawley rats were randomly divided into six groups with nine rats
each. Control group rats were fed a normal diet, and bilateral acu-point Fenglong (equivalent
to ST40 in humans) on the hind legs were covered with a placebo (general mucilage) for 2 hours
each day. Model group rats were fed a high-lipid diet for 2 weeks. Therapy group rats were fed
a high-lipid diet for 2 weeks and then administered crude-herb moxibustion at ST40 for 2 hours
each day for the next 2 weeks. Prevention group rats were administered crude-herb moxibus-
tion 2 hours a day for 2 weeks and then fed a high-lipid diet for the subsequent 2 weeks. Pre-
vention/Therapy group rats were each administered crude-herb moxibustion at ST40 for
2 hours each day for 2 weeks, followed by a high-lipid diet for the next 2 weeks, and then
crude-herb moxibustion again at ST40 for another 2 weeks. Simvastatin group rats were fed
a high-lipid diet for 2 weeks and then treated with simvastatin for the next 2 weeks. Blood
lipids, hepatosomatic indices (HSIs) and epididymal fat pad weights of all rats were examined.
Results: Compared with the Model group, levels of total cholesterol (TC), glycerinate, low-
density lipoprotein cholesterol (LDL-C) and very low-density lipoprotein cholesterol (VLDL-C)
in plasma collected from the Therapy group, the Prevention/Therapy group, and the Simva-
statin group were decreased. Moreover, compared with the Model group, HSIs in Therapy group
rats were also decreased following administration of crude-herb moxibustion, but TC, TG, HDL-
C, LDL-C, and VLDL-C levels in the Prevention group were higher than those in the Model group.cupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing 100029, China.
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Effect of crude-herb moxibustion in rats 141Conclusion: The results reveal that blood lipids and HSIs appear to be modulated by the effect
of crude-herb moxibustion and suggest therapeutic strategies for the treatment of dyslipide-
mia.
ª 2015 Beijing University of Chinese Medicine. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/3.0/).Introduction
Dyslipidemia is a metabolic disorder characterized by
elevated levels of serum lipoproteins 1. Dyslipidemia is one
of the most important risk factors for coronary heart dis-
ease (CHD) and has been identified as the leading cause of
death worldwide, causing global social and economic
burden 2,3. CHD is associated with obesity, type 2 diabetes
mellitus, hypertension, stroke, and especially atheroscle-
rosis 4,5. The overall pooled prevalence of dyslipidemia in
Chinese adults was estimated to be 41.9%, with a higher
rate in men than in women 6.
Common drugs for dyslipidemia include niacin, folic acid
derivatives, bile acid-binding resins, and 3-hydroxy-3-
methyl-glutaryl-coenzyme A (HMG-CoA) reductase in-
hibitors, which are commonly known as statins. As one of
the most widely used statin, simvastatin is highly selective
for liver functions, inhibits synthesis of endogenous
cholesterol, thus decreasing blood lipids. Simvastatin is a
typical lipid lowering drug 7. In numerous placebo-
controlled clinical trials, statins have been shown to have
well-defined safety profiles, but their side effects include
liver damage and a small risk of muscle problems, such as
myalgia, mild myositis, creatine kinase (CK) elevations, and
rhabdomyolysis 8. Previous clinical research indicates that
mild myositis appears most often in controlled trials at an
estimated rate of 5%e10% 9.
In traditional Chinese medicine (TCM), description of
symptoms of the condition similar to dyslipidemia is found
in the ancient text, Yellow Emperor’s Inner Classic. In TCM,
dyslipidemia is caused by a syndrome known as phlegm
obstruction 10. The acupoint Fenglong(ST40) is typically
used to treat phlegm obstruction 11. Accumulating evidence
shows that acupuncture applied to ST40 has preventive and
therapeutic effect on dyslipidemia, cardiovascular dis-
eases, obesity, type 2 diabetes, hypertension, and
stroke 12. Electro-acupuncture (EA) or moxibustion applied
to ST40 decreases plasma total cholesterol (TC) and low-
density lipoprotein cholesterol (LDL-C), and increases
high-density lipoprotein cholesterol (HDL-C) levels in dys-
lipidemic rats 13. Acupuncture at ST40 also promotes he-
patic gene expression and thus accelerates reversal of
cholesterol transport and alleviates fat accumulation inside
hepatocytes 14. Additionally, acupuncture at ST40 in the rat
model of hyperlipidemia lowers serum malondialdehyde
(MDA) and endothelin-1 (ET-1) levels and improves super-
oxide dismutase (SOD) activity and nitric oxide (NO) and
calcitonin gene-related peptide (CGRP) contents, and mit-
igates lipid peroxidation, clears free radicals 15,16. Studies
in the mice model of hyperlipidemia showed that
acupuncture at ST40 regulates and ameliorates the meta-
bolic balance of free radicals, and protects vascularendothelia 17,18. At the gene level, research has shown that
EA at ST40 in rats may have therapeutic effect on dyslipi-
demia that are mediated by increasing the expressions of
the ABCA1, PPARa, LXR-a, and RXR-amRNA, thus promoting
the reversal of cholesterol transport 19.
Traditional Chinese herbal medicines influence multiple
mechanisms in the human body. With regard to dyslipide-
mia, the herb hawthorn fruit (Crataegus pinnatifida Bge.
var. major N. E. Br.) has been found to significantly
decrease serum triglyceride (TG), TC, and LDL-C, and to
reduce scores of pathologic changes due to hyperlipidemia
while increasing HDL-C level 20,21.
Another TCM modality is crude-herb moxibustion, one of
moxibustion therapies. Crude-herb moxibustion is applica-
tion applied to the acupoint or the affected part with the
herb of a constant irritant to skin till it presents red color,
wistful or intravenous induction. Crude-herb moxibustion
involves the synergistic effects of Chinese herbs and local
acupoints.
Clinical research has found that crude-herb moxibustion
is efficacious in the treatment of dyslipidemia. Crude-herb
moxibustion applied to dyslipidemic rats can regulate gen-
eral and liver fat metabolism, reduce fat deposits in the
liver, inhibit fatty degeneration of liver cells, and restore
normal liver cell function 22. However, this report did find
that crude-herb moxibustion exacerbates dyslipidemia 28.
Thus, more evidence is needed to validate the effects of
crude-herb moxibustion on dyslipidemia.
This study investigated the therapeutic and preventive
effects of the application of crude-herb moxibustion to
acupoint ST40 in rats with dyslipidemia.Materials and methods
Experimental animals
Fifty-four SpragueeDawley rats (7 weeks old, 180 ge220 g)
were acquired from Vital River Laboratories (Beijing, China)
and housed in stainless steel cages in a controlled envi-
ronment at 24C1C and 70% relative humidity and
maintained on a 12 hours lightedark cycle for at least 6
days prior to the experiments. The protocol was approved
by Animal Care and Use Review Committee of Beijing Uni-
versity of Chinese Medicine and was in accord with the
ethics guidelines of Beijing University of Chinese Medicine.
Preparations prior to crude-herb moxibustion
At the age of 8 weeks and after 1 week of acclimatizing to
laboratory conditions, the rats were randomly assigned to
either a control or a high-lipid diet (nZ 9 rats/group). Body
142 L. Duan et al.weight and food intake were recorded every 24 hours. The
rats remained on their respective diets for 2 weeks. After
fasting for 12 hours overnight, the rats were weighed.
Experimental animal grouping
Control group rats were fed a normal rat chow diet, and the
acupoint ST40 of each hind leg was covered for 2 hours each
day with a placebo consisting of general mucilage. Model
group rats were fed a high-lipid rat chow diet for 2 weeks.
Therapy group rats were fed a high-lipid diet for 2 weeks
and then administered crude-herb moxibustion at bilateral
ST 40 for 2 hours a day for the following 2 weeks. Preven-
tion group rats were administered crude-herb moxibustion
for 2 hours at bilateral ST40 each day for 2 weeks and then
fed high-lipid diet for the following 2 weeks. Prevention/
Therapy group rats were administered crude-herb moxi-
bustion at bilateral ST40 for 2 hours each day for 2 weeks
and then fed a high-lipid diet for the following 2 weeks, and
subsequently underwent crude-herb moxibustion for 2
weeks. Simvastatin group rats were fed a high-lipid diet for
2 weeks and then treated with simvastatin at a dose of
4 mg/kg/d for an additional 2 weeks. Body weights of all
rats were recorded daily.
Crude-herb moxibustion treatment
Prescription and preparation of the crude-herb
moxibustion paste
The crude-herb prescription used in this study was refer-
enced from Chinese Acupoint Application Therapy 23. Herbs
in the prescription were evodia fruit (Evodia rutaecarpa
(Juss.) Benth. (Rutaceae)), 100 g; cuttle fish bone (Sepia
esculenta Hoyle), 100 g; notoginseng root (Panax noto-
ginseng (Burk.) F. H. Chen (Araliaceae)), 30 g; dragon’s
blood resin (Daemonorops draco Bl. (Palmae)), 30 g;
chicken gizzard lining (of Gallus gallus domesticus), 50 g;
processed pinellia rhizome (Pinellia ternate (Thunb.)
Breit.), 50 g; aged tangerine peel (Citrus reticulata
Blanco), 20 g; turmeric rhizome (Curcuma longa L. (Zingi-
beraceae)), 15 g; hawthorn fruit (Crataegus pinnatifida
Bge. var. major N. E. Br.), 30 g; and white mustard seed
(Sinapis alba L.), 100 g. All of the ingredients with the
exceptions of dragon’s blood powder and notoginseng root
powder were diluted 10-fold in water and boiled twice for
1.5 hours each time to create a concentrated liquid
extract. The water and oil phases of the substrate were
placed in a beaker and a conical flask with plug, respec-
tively, and heated in water bath at 80C. The liquid extract,
powders of Dragon’s blood and Notoginseng root were set in
the water phase and mixed. The water phase was poured
into the oil phase and then mixed again for 5 minutes at
80C. The compound was removed, milled, and refrigerated
in the mortar. The liquid extract weighed 440 g. The sub-
strate was composed of albolene (40 g), glycerin mono-
stearate (10 g), adeps lanae (10 g), Tween-80 (48 g), and
Span-60 (12 g), glycerin (40 g). The crude-herb liquid
extract and substrate were mixed together to make a
paste. The paste was processed by the Chinese Pharmacy
School of Beijing University of Chinese Medicine.Selection and stimulation of acupoints
Based on the animal acupoint reference book Experimental
Acupuncture Science 24, ST40 in the rat is at the midpoint of
the posterior margin of the fibula (Fig. 1).
Method of crude-herb moxibustion
The day before treatment, an area of approximately 1 cm
over the surface of ST40 was depilated. On the day of
treatment, the rats were bagged and their hind legs were
exposed outside of the bag. The herbal paste was mixed
with minced ginger (3 g) and garlic (3 g) and smeared on
ST40 over an area of approximately 0.7 cm. Two hours
later, the paste was washed off with water. The sites
exhibited some redness but no blisters.Test methods
Procedure
All rats were fasted for 12 hours overnight, weighed, and
then anesthetized with urethane dissolved in distilled
water and injected intraperitoneally (i.p.) at a dose of
4 mg/kg. Anesthesia was deemed adequately when pedal
reflexes were no longer present. The rats were placed on a
small platform and their limbs secured. The gross anatomy
was observed, and 1.5 mL of blood was drawn from the
abdominal aorta and placed in a Vacutainer blood collec-
tion tube. The blood samples were centrifuged at 2000 g for
10 minutes at 4C. The plasma was then collected to
determine levels of TC, TG, LDL-C, and HDL-C. The entire
liver and one side of the epididymal fat pad were rapidly
dissected out, and their weights recorded. The samples
were then stored at 80C.
Hepatosomatic index and epididymal fat pad weight
Hepatosomatic index (HIS) is the ratio of liver weight to
body weight 25. After adaptive feeding, the rats were
weighed. Before anesthesia, the rats were weighed again.
The weight was measured twice, and its change obtained.
Epididymal fat pad weight was taken as the weight of one
side of the epididymal fat pad 26,27.
TC, TG, LDL-C, and HDL-C levels
Standard kits from Beckman Ltd. (Fullerton, CA, USA) were
used for the quantitative determination of plasma tri-
glycerides, cholesterol, HDL-C, LDL-C, and VLDL-C, which
were measured with an auto analyzer (Beckman In-
struments 5821, Fullerton, CA, USA) using their respective
standards. Triglycerides and cholesterol were used with the
peroxidase method, and HDL-C, LDL-C, VLDL-C were
assessed using the direct method.Statistical analyses
The analyses were performed with the SPSS 18.0 statistical
software. Data are presented as the means  the SEMs. The
groups were compared with one-way ANOVAs and Tukey’s
tests. P values below 0.05 were considered significant.
Figure 1 Location of ST40 in the rat.
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Effect of crude-herb moxibustion on TC, TG, LDL-C,
and HDL-C
Total cholesterol level in the Model group was significantly
higher (by seven fold) than that in the Control group
(P < 0.05) (Fig. 2). TC levels were significantly lower in the
Therapy group and in the Prevention/Therapy and Simva-
statin group compared with the Model group (P Z 0.000,
P Z 0.038, P Z 0.000, and P Z 0.039, respectively). Sur-
prisingly, compared with the Model group, TC level in the
Prevention group was elevated (P Z 0.025). Moreover, TC
levels in the Therapy group and Prevention/Therapy group
were similar to that of the Simvastatin group (Fig. 2).
Triglyceride level in the Model group was significantly
different from that of the Control group (P Z 0.038).
Compared with the Model group, TG levels in the Therapy
group and in the Prevention group were elevated, but these
differences were not significant (PZ 0.249). TG level in theFigure 2 Total cholesterol levels among different rat groups.
**: P < 0.01 significantly different from Control group.
#: P < 0.05, ##: P < 0.01 significantly different from Model
group.Prevention/Therapy group was lower than that of the Model
group and similar to that of the Simvastatin group (Fig. 3).
HDL-C level in the Model group was markedly increased
compared to that of the Control group (PZ 0.000) (Fig. 4).
Compared with the Model group, HDL-C level in the Pre-
vention group was elevated (PZ 0.074), but HDL-C levels in
the Therapy group, Prevention/Therapy group, and Simva-
statin group were decreased compared to that of the Model
group (Fig. 4).
The LDL-C level in the Model group was 15-fold greater
than that of the Control group (P Z 0.000) (Fig. 5). How-
ever, levels of LDL-C in the Therapy group and Prevention/
Therapy and Simvastatin group were extremely reduced
compared with that of the Model group (Fig. 5).
VLDL-C level in the Model group was significantly
different from that of the Control group (P Z 0.039)
(Fig. 6). VLDL-C level in the Prevention group was higher
than that of the Model group, but this difference was not
significant (P Z 0.254). Compared with the Model group,
levels of VLDL-C in the Therapy group were elevated, but
level in the Prevention/Therapy group was lower, although
these differences were not significant (P Z 0.249) (Fig. 6).Figure 3 Triglyceride levels among different rat groups.
**: P < 0.01 significantly different from Control group.
Figure 6 VLDL-C levels among different rat groups. **:
P < 0.01 significantly different from Control group.Figure 4 HDL-C levels among different rat groups. **:
P < 0.01 significantly different from Control group; #: P < 0.05,
##: P < 0.01 significantly different from Model group.
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change, and epididymal fat pad weight
There was a significant difference between the rats in the
Control group and those in the Model group (P Z 0.000)
(Fig. 7). Levels of HSI in the Therapy group, Prevention/
Therapy group, and the Simvastatin group were signifi-
cantly decreased compared to that of the Model group
(P Z 0.000, P Z 0.000, P Z 0.001, and P Z 0.000,
respectively). Body weight in the Model group were
slightly reduced compared to that of the Control group.
Rats in the Prevention/Therapy group were the heaviest of
all groups. Epididymal fat pad weight was similar across all
groups.Figure 5 LDL-C levels among different rat groups. **:
P < 0.01 significantly different from Control group; #: P < 0.05,
##: P < 0.01 significantly different from Model group.In summary, the levels of TC, TG, LDL-C, and VLDL-C in
the Therapy group, Prevention group, Prevention/Therapy
group and Simvastatin group were significantly decreased,
whereas level of HDL-C was decreased compared with that
of the Model group.
Discussion
Blood lipids, weight, and HSI
Our study revealed that crude-herb moxibustion adminis-
tered at acupoint ST40 prevented and treated dyslipidemia
in rats caused by high-lipid diet. Specifically, crude-herb
moxibustion appears to exert a regulatory effect on levels
of TG, HDL-C, and LDL-C. Additionally, crude-herb moxi-
bustion decreased levels of TC, LDL-C, and HSI and slightly
elevated VLDL-C. These results show that crude-herb
moxibustion might have preventive and therapeutic effect
against dyslipidemia and thus atherosclerosis.
In this study, a rat model of dyslipidemia was suc-
cessfully implemented with a high-lipid diet over 2
weeks. The levels of blood lipids in the Therapy group,
Prevention/Therapy group, and Simvastatin group exhibi-
ted notable decreases compared with the Model group.
These results may indicate that crude-herb moxibustion
causes a decrease in blood lipids, though rats in the
Prevention group exhibited higher blood lipid levels than
rats in the Model group. Thus, when applied preventively,
crude-herb moxibustion might be associated with a risk of
elevated blood lipids. More research is needed for
explanation. Interestingly however, the effect of moxi-
bustion observed in the Prevention/Therapy group was
better than that observed in the Therapy group. It
probably benefits from more quantity of stimulus. These
findings indicate that prevention and therapy with crude-
herb moxibustion had a more positive effect than crude-
herb moxibustion alone in rats with dyslipidemia but the
preventive effect of crude-herb moxibustion require
further exploration.
Crude-herb moxibustion and Simvastatin had therapeu-
tic effect on HSI. Dyslipidemia results in liver weight gain,
Figure 7 Comparison of the HIS, weight change and epididymal fat weight levels among different rat groups. **:P < 0.01
significantly different from Control group; ##: P < 0.05 significantly different from Model group.
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was markedly elevated in dyslipidemic rats compared with
normal rats. Crude-herb moxibustion significantly
decreased HSI in SD mice compared with that of the Model
group, hence preventing liver weight gain, which indicates
that such treatment might protect the liver from blood lipid
accumulation.
Body weight decrease indicated that dyslipidemia does
not always induce weight gain and weight gain does not
always coincide with a rise in blood lipids. Although the
body mass index is positively correlated with the risk of
dyslipidemia and is clinically predictive of dyslipidemia 28,
there is evidence that changes in blood fat are unrelated to
weight 29. One likely explanation is that rats in the Model
group were not accustomed to the high-lipid diet and
reduced food intake. However, the blood lipid disorders in
the rats resulted from damage due to the intake of high-
lipid food, which did not lead to obesity in the short-
term. Additionally, although high-lipid diet led to a
decrease in body weight, the impact of the diet was less
than that of natural growth. Thus, the body weight of the
Prevention/Therapy group increased over a longer period,
and the high-lipid diet was withdrawn at a later time.The epididymal fat pad weight was not different among
the groups. Ineffectiveness might result from the fact that
the short-term high-lipid diet did not bring about changes in
body fat.
Results of our study are in accord with those of previous
research regarding crude-herb moxibustion 30. Our results
revealed that crude-herb moxibustion seemed regulate
general and liver fat metabolism.Comparative analysis of crude-herb moxibustion,
preventive crude-herb moxibustion, and
simvastatin
Compared with the Model group, TG level in the Preven-
tion/Therapy group was slightly reduced; however, other
measures (i.e. TC, HDL-C, LDL-C, VLDL-C, HSI, body weight,
and epididymal fat pad weight) did not exhibit differences.
Thus, preventive crude-herb moxibustion did not show good
effect on rats with dyslipidemia. The probable reason for
this finding is that preventive treatments for dyslipidemia
need to be individualized. In TCM, doctors focus on syn-
drome differentiation and provide targeted therapy to
146 L. Duan et al.transform the patient’s condition from dysharmony to
harmony. Moreover, increasing evidence suggests that
crude-herb moxibustions applied after syndrome differen-
tiation has superior effect 31.
However, the mechanisms of the effect of crude-herb
moxibustion on dyslipidemia remain unknown. After 2
weeks of therapy, rats in the Therapy group and the
Simvastatin group exhibited blood lipid levels that were
similar to that of the Control group. These findings indi-
cate that dyslipidemia can be regulated with therapy and
that crude-herb moxibustion had positive effect.
Compared with the Simvastatin group, the Crude-herb
moxibustion group exhibited better results in terms of
LDL-C level but worse results in terms of TC, TG, HDL-C,
and VLDL-C levels.
The present study has limitation. The process of dysli-
pidemia model might be reversible. This study found that
rats recovered from dyslipidemia beginning on Day 12 of the
high-lipid diet. However, there is longer feed time in the
Prevention/Therapy group, so this group has less reliability.Conclusions
This study revealed the therapeutic effect of crude-herb
moxibustion on rats with dyslipidemia. Future studies are
needed to elucidate the mechanism of crude-herb moxi-
bustion and how individual ingredients contribute to the
combined pharmacologic efficacy. Moreover, the question
raised in this study regarding tendency toward body weight
changes and weight changes of the epididymal fat pads are
also to be explored in future research.Funding
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